Needed: New and Better Tools to Combat Latent Tuberculosis Infection

被引：3
作者：
Blumberg, Henry M. [1 ]
机构：
[1] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30303 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2008年 / 149卷 / 10期
关键词：
D O I：
10.7326/0003-4819-149-10-200811180-00011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：761 / 763
页数：3
相关论文
共 23 条
[1]  
[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603
[2]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[3]  
[Anonymous], CLIN INFECT DIS
[4]   Update on rifampin and rifabutin drug interactions [J].
Baciewicz, Anne M. ;
Chrisman, Cary R. ;
Finch, Christopher K. ;
Self, Timothy H. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2008, 335 (02) :126-136
[5]   Prevalence of tuberculosis infection in the United States population - The National Health and Nutrition Examination Survey, 1999-2000 [J].
Bennett, Diane E. ;
Courval, Jeanne M. ;
Onorato, Ida ;
Agerton, Tracy ;
Gibson, Judy D. ;
Lambert, Lauren ;
McQuillan, Geraldine M. ;
Lewis, Brenda ;
Navin, Thomas R. ;
Castro, Kenneth G. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (03) :348-355
[6]   Update on the treatment of tuberculosis and latent tuberculosis infection [J].
Blumberg, HM ;
Leonard, MK ;
Jasmer, RM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (22) :2776-2784
[7]  
Burman W, 2008, INT J TUBERC LUNG D, V12, P111
[8]   TOXIC EFFECTS OF ISONIAZID IN TUBERCULOSIS CHEMOPROPHYLAXIS - ROLE OF BIOCHEMICAL MONITORING IN 1,000 PATIENTS [J].
BYRD, RB ;
HORN, BR ;
SOLOMON, DA ;
GRIGGS, GA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (12) :1239-1241
[9]  
*CAN THOR SOC PUBL, CAN TUB STAND
[10]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P735
123